[go: up one dir, main page]

DE69835424D1 - Boviner atmungs- und darmcoronavirus als impfstoff - Google Patents

Boviner atmungs- und darmcoronavirus als impfstoff

Info

Publication number
DE69835424D1
DE69835424D1 DE69835424T DE69835424T DE69835424D1 DE 69835424 D1 DE69835424 D1 DE 69835424D1 DE 69835424 T DE69835424 T DE 69835424T DE 69835424 T DE69835424 T DE 69835424T DE 69835424 D1 DE69835424 D1 DE 69835424D1
Authority
DE
Germany
Prior art keywords
bovine
coronavirus
vaccine
darm
breathing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69835424T
Other languages
English (en)
Other versions
DE69835424T2 (de
Inventor
C Stine
J Mcginley
A Anderson
L Stine
K Brown
D Dory
Adrian Liem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMTECH BIOLOG LLC
Bayer Corp
Original Assignee
IMMTECH BIOLOG LLC
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMTECH BIOLOG LLC, Bayer Corp filed Critical IMMTECH BIOLOG LLC
Application granted granted Critical
Publication of DE69835424D1 publication Critical patent/DE69835424D1/de
Publication of DE69835424T2 publication Critical patent/DE69835424T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE1998635424 1997-03-10 1998-03-04 Boviner atmungs- und darmcoronavirus als impfstoff Expired - Fee Related DE69835424T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81431197A 1997-03-10 1997-03-10
US814311 1997-03-10
PCT/US1998/004392 WO1998040097A2 (en) 1997-03-10 1998-03-04 Bovine respiratory and enteric coronavirus as a vaccine

Publications (2)

Publication Number Publication Date
DE69835424D1 true DE69835424D1 (de) 2006-09-14
DE69835424T2 DE69835424T2 (de) 2007-02-08

Family

ID=25214684

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1998635424 Expired - Fee Related DE69835424T2 (de) 1997-03-10 1998-03-04 Boviner atmungs- und darmcoronavirus als impfstoff

Country Status (13)

Country Link
EP (1) EP0975360B1 (de)
JP (1) JP2001519781A (de)
KR (1) KR100531491B1 (de)
CN (1) CN1283315C (de)
AT (1) ATE334697T1 (de)
AU (1) AU725439B2 (de)
BR (1) BR9808226A (de)
CA (1) CA2231591A1 (de)
DE (1) DE69835424T2 (de)
DK (1) DK0975360T3 (de)
ES (1) ES2270508T3 (de)
NZ (1) NZ337702A (de)
WO (1) WO1998040097A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CA2471968C (en) * 2001-10-06 2013-07-23 Merial Limited Immunostimulatory nucleic acids and use thereof
CN102021147B (zh) * 2003-03-24 2016-08-03 港大科桥有限公司 引起严重急性呼吸道综合征(sars)的新型人病毒及其应用
CN100543132C (zh) * 2003-03-24 2009-09-23 香港大学 引起严重急性呼吸道综合征(sars)的新型人病毒及其应用
US7320857B2 (en) * 2003-06-18 2008-01-22 Chinese National Human Genome Center At Shanghai Characterization of the earliest stages of the severe acute respiratory syndrome (SARS) virus and uses thereof
CN1318580C (zh) * 2003-07-10 2007-05-30 北京科兴生物制品有限公司 可满足灭活疫苗生产的sars病毒规模化制备及灭活的方法
CA2699024C (en) 2009-11-06 2016-12-13 Intervet International B.V. Methods of immunizing pregnant heifers at three months of gestation
CA2957472C (en) 2014-09-03 2021-10-26 Intervet International B.V. Attenuated bovine coronavirus and related vaccines
CN111117975A (zh) * 2020-01-03 2020-05-08 西南民族大学 牛冠状病毒he基因重组株及其制备的灭活疫苗和应用
CN113322241B (zh) * 2021-05-14 2023-06-13 金宇保灵生物药品有限公司 一种牛副流感病毒3型病毒株bpiv3-nm及其应用
CN117286111B (zh) * 2023-03-13 2024-06-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 牛冠状病毒分离株、稳定表达牛冠状病毒n蛋白细胞系及在构建反向遗传操作系统中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580778A (en) * 1994-06-15 1996-12-03 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Isolation and diagnosis of coronaviruses as a factor in bovine shipping fever, and a cell line for culturing both those and other bovine coronaviruses
ES2224172T3 (es) * 1995-06-12 2005-03-01 Kansas State University Research Foundation Vacuna multivalente de coronavirus bovino y metodo para tratar la infeccion por coronavirus bovino.

Also Published As

Publication number Publication date
ES2270508T3 (es) 2007-04-01
DK0975360T3 (da) 2006-11-27
AU725439B2 (en) 2000-10-12
NZ337702A (en) 2001-05-25
EP0975360A2 (de) 2000-02-02
WO1998040097A3 (en) 1999-01-14
BR9808226A (pt) 2000-05-16
JP2001519781A (ja) 2001-10-23
CA2231591A1 (en) 1998-09-10
ATE334697T1 (de) 2006-08-15
WO1998040097A2 (en) 1998-09-17
KR20000075775A (ko) 2000-12-26
AU6346598A (en) 1998-09-29
KR100531491B1 (ko) 2005-11-28
CN1250380A (zh) 2000-04-12
EP0975360B1 (de) 2006-08-02
DE69835424T2 (de) 2007-02-08
CN1283315C (zh) 2006-11-08

Similar Documents

Publication Publication Date Title
TR200002855T2 (tr) Raloksifenin solunum yolu ile veya burundan uygulanması.
NO982497D0 (no) Vaksine-sammensetninger for inntak gjennom nesen
NO991524L (no) Vaksiner
ATE264691T1 (de) Newcastle-krankheitsvirus-kombinationsimpfstoff
DE69704011D1 (de) Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Sweins (PRRSV)
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
DE60210456D1 (de) Solubisierung von kapseln polysacchariden
DE60125797D1 (de) Impfstoffzusammesetzung
FI964592A0 (fi) Papilloomavirusrokotteita
DK1079857T3 (da) Meningitidis B/C-kombinationsvacciner
DE69835424D1 (de) Boviner atmungs- und darmcoronavirus als impfstoff
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
AU7814498A (en) Multivalent (in ovo) avian vaccine
HUP9901958A2 (hu) Sertés reproduktív és respirációs szindróma vakcina
HUP0000362A2 (hu) Madár-reovírusok új antigén osztálya
DE69738641D1 (de) Lebend-impfstoff gegen heliobacter pylori
BR0002826A (pt) Desfolhadeira mecânica
PT744027E (pt) Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos
BR0209145A (pt) Vacina contra varìola
DK1343896T3 (da) Lille syreoplöseligt sporeprotein og anvendelser deraf
ATE283066T1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
HUP0101652A1 (hu) Új kompozíció
PT796256E (pt) Novos processos de preparacao da ranitidina
BR9711138A (pt) Prepara-{es de herperv¡rus equino com prote-Æo mÚtua e m-todo de fazer e usar as mesmas
UA67258A (en) Strain neonatal calf diarrhea coronavirus "bc-1" for the preparation of vaccines and diagnosticums

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee